바로가기메뉴

본문 바로가기 주메뉴 바로가기

2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2022, v.85 no.1, pp.1-10
https://doi.org/10.4046/trd.2021.0022
Hyuk-Jae Chang, M.D., Ph.D. (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)
Jae-Hyeong Park, M.D., Ph.D. (Department of Cardiology in Internal Medicine, Chungnam National University Hospital)
Jin Oh Na, M.D., Ph.D. (Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine)
Jae Seung Lee, M.D., Ph.D. (Asan Medical Center, University of Ulsan College of Medicine)
Yee Hyung Kim, M.D., Ph.D. (Kyung Hee University Hospital)
on behalf of Joint Task Force for the Diagnosis and Treatment of Pulmo
  • Downloaded
  • Viewed

Abstract

Pulmonary hypertension (PH) is a condition of increased blood pressure in the pulmonary arteries and is diagnosedwith an increased a mean pulmonary artery pressure ≥25 mm Hg. This condition may be associated with multipleclinical situations. Based on pathophysiological mechanisms, clinical presentation, hemodynamic profiles, andtreatment strategies, the patients were classified into five clinical groups. Although there have been major advances inthe management of PH, it is still associated with significant morbidity and mortality. The diagnosis and treatment of PHhave been performed mainly by following European guidelines, even in Korea because the country lacks localized PHguidelines. European treatment guidelines do not reflect the actual status of Korea. Therefore, the European diagnosisand treatment of PH have not been tailored well to suit the needs of Korean patients with PH. To address this issue, wedeveloped this guideline to facilitate the diagnosis and treatment of PH appropriately in Korea, a country where theconsensus for the diagnosis and treatment of PH remains insufficient. This is the first edition of the guidelines for thediagnosis and treatment of PH in Korea, and it is primarily based on the ‘2015 ESC/ERS Guidelines for the diagnosis andtreatment of pulmonary hypertension.’ with the acceptance and adaptation of recent publications of PH.

keywords
Pulmonary Hypertension, Treatment, Pulmonary Arterial Hypertension, Guidelines

Tuberculosis & Respiratory Diseases